New Modality of Collapse Therapy for Pulmonary Tuberculosis Sequels: Tissue Expander

Bertin, F.; Labrousse, Louis; Gazaille, V.; Vincent, François; Guerlin, A.; Laskar, Marc

doi:10.1016/j.athoracsur.2007.04.013

Cited by 13 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Historical procedures are summarized in Table 4, diagnostic procedures in Table 5, and surgical procedures in Table 6. 46–50 It is important to understand that resectional operations (lobectomy, pneumonectomy) differ from those in cancer cases. There is more operative bleeding and air leaks, due to dense pleural adhesions and parenchymal lung injury.…”

Section: Operative Aspectsmentioning

confidence: 99%

Surgical aspects of pulmonary tuberculosis: an update

Dewan

Pezzella

2016

Asian Cardiovasc Thorac Ann

View full text Add to dashboard Cite

Tuberculosis remains a major global medical challenge and concern. In the world's population of over 7.4 billion people, 8.6 million are estimated to be infected with Mycobacterium tuberculosis; another 2.2 billion have latent tuberculosis. There is an annual incidence of 16,000 new cases in the USA and 7-8 million new cases worldwide, of which 440,000 are multidrug-resistant or extensively multidrug-resistant, mainly in developing countries or emerging economies. According to the World Health Organization, the incidence of tuberculosis is 133 cases per 100,000 of the population; 3.3% new cases are drug resistant and 20% are already treated cases. Of the drug-resistant cases, 9.7% are extensively drug-resistant. The annual global mortality attributable to tuberculosis is over 1.3 million people. The association with HIV/AIDS in 430,000 people has compounded the global concern and challenge. This review presents the historical indications for surgical treatment of tuberculosis, reviews the current literature and clinical experience, and collates this into increased awareness and contemporary understanding of the indications and need for surgery in primary active tuberculosis, adjuvant surgical therapy for multidrug-resistant tuberculosis, and the complications of chronic tuberculosis sequelae or previous tuberculosis surgery.

show abstract

Section: Operative Aspectsmentioning

confidence: 99%

Surgical aspects of pulmonary tuberculosis: an update

Dewan

Pezzella

2016

Asian Cardiovasc Thorac Ann

View full text Add to dashboard Cite

show abstract

“…We also postulate that EBVs might be an attractive option for patients who develop AL from cavitary pulmonary TB, especially in the geographical areas with endemicity for the disease. Lung collapse therapy for treating pulmonary TB has been described in the literature [27]. The use of EBVs to treat AL in patients with pulmonary TB contributed to lung expansion by assisting in sealing the AL rather than causing lung collapse.…”

Section: Discussionmentioning

confidence: 98%

Endobronchial Valves in the Management of Broncho-Pleural and Alveolo-Pleural Fistulae

El-Sameed

Waness

Shamsi

et al. 2012

Lung

View full text Add to dashboard Cite

Pneumothorax from bronchopleural or alveolo-pleural fistulae can be complicated by prolonged air leak (AL). This can occur in a variety of clinical settings. Examples include structural lung disease, such as bronchiectasis, and cavitary lung disorders. Prolonged AL is associated with prolonged hospital stay, atelectasis, pneumonia, and thromboembolic disease. Endobronchial valves (EBVs) have been recently introduced to manage such situations. The global experience in this novel therapeutic modality is still evolving. We report our preliminary experience with managing persistent AL treated successfully with EBVs and review the current literature on this subject. Our experience shows that EBVs are an effective tool for the management of prolonged AL from persistent bronchopleural or alveolo-pleural fistulae. It is a minimally invasive procedure recommended as an option, particularly in patients not fit for surgical repair.

show abstract

“…Varios autores ya demostraron la utilidad de esta técnica con materiales expandibles; Bertin y colaboradores en 2007 realizaron colapsoterapia en un paciente de 29 años con tuberculosis multidrogorresistente asociada a una caverna, utilizando un expansor tisular de silicona con buenos resultados a corto plazo (13); y aun más recientemente Khan y colaboradores en 2015 probaron la efectividad de este procedimiento en una paciente de 34 años con una caverna como secuela de una tuberculosis sobreinfectada con Aspergilus con pobre respuesta al tratamiento, utilizando una protesis mamaria expandible con buenos resultados a corto y mediano plazo (14). Debido al surgimiento de cepas de tuberculosis multidrogorresistente y de pacientes persistentemente bacilíferos con grandes lesiones cavernomatosas asociadas, la colapsoterapia se covertirá nuevamente en una indicación terapéutica en la que se utilizarán, como material de plombaje, prótesis expandibles ampliamente tecnificadas y probadas en la cirugía estética que permitirán reducir complicaciones tanto tempranas como tardías.…”

Section: Discussionunclassified

Colapsoterapia con protesis mamaria expandible en el tratamiento de la tuberculosis pulmonar

Moreno

Ocampo

Uribe

2017

rev. colomb. neumol.

View full text Add to dashboard Cite

La colapsoterapia es una técnica usada para obliterar lesiones cavernomatosas por destrucción pulmonar como secuelas de infecciones por tuberculosis. Fue descrita inicialmente en 1882 y se utilizaron diversos materiales como tejido adiposo y óseo, mezcla de varias parafinas y esferas de polimetilmetacrilato (esferas de Lucite), que causaron complicaciones importantes. Con el advenimiento de la terapia antibiótica disminuyó su uso dada la excelente respuesta al tratamiento. En la actualidad y en especial por la aparición de cepas multidrogorresistentes, se están presentado casos nuevos de pacientes con cavernas extensas cuya única opción terapéutica es la intervención quirúrgica para obliterar la caverna. En este contexto, desempeña, un papel importante las prótesis mamarias expandibles ya que disminuyen las complicaciones generadas por las técnicas empleadas en el pasado. Se expone el caso de un paciente de 49 años con tuberculosis de difícil manejo asociada a gran caverna pulmonar tratada con colapsoterapia con prótesis mamaria expandible con respuesta excelente a corto plazo.

show abstract

New Modality of Collapse Therapy for Pulmonary Tuberculosis Sequels: Tissue Expander

Cited by 13 publications

References 7 publications

Surgical aspects of pulmonary tuberculosis: an update

Surgical aspects of pulmonary tuberculosis: an update

Endobronchial Valves in the Management of Broncho-Pleural and Alveolo-Pleural Fistulae

Colapsoterapia con protesis mamaria expandible en el tratamiento de la tuberculosis pulmonar

Contact Info

Product

Resources

About